NSC2039
dc.creator | US National Cancer Institute | en_GB |
dc.date.accessioned | 2004-12-12T17:26:53Z | |
dc.date.available | 2004-12-12T17:26:53Z | |
dc.date.created | 2003-02-01 | en_GB |
dc.date.issued | 2004-12-12T17:26:53Z | |
dc.format.extent | 3451 bytes | |
dc.format.extent | 4063 bytes | |
dc.format.mimetype | chemical/x-cml | |
dc.format.mimetype | chemical/x-cml | |
dc.identifier | NSC2039 | en_GB |
dc.identifier.ichi | C9H7NO,11H-8-5H-1H-3H-7-4H-2H-6H-10-9(7)8 | en_GB |
dc.identifier.inchi | InChI=1S/C9H7NO/c11-8-5-1-3-7-4-2-6-10-9(7)8/h1-6,11H | |
dc.identifier.inchikey | MCJGNVYPOGVAJF-UHFFFAOYSA-N | |
dc.identifier.uri | http://www.dspace.cam.ac.uk/handle/1810/3519 | |
dc.language.iso | en_GB | |
dc.publisher | Unilever Center for Molecular Informatics, Cambridge University | en_GB |
dc.title | NSC2039 | en_GB |
dc.title.alternative | Bioquin | en_GB |
dc.title.alternative | Fennosan H 30 | en_GB |
dc.title.alternative | Hydroxybenzopyridine | en_GB |
dc.title.alternative | NCI-C55298 | en_GB |
dc.title.alternative | Oxin | en_GB |
dc.title.alternative | Oxine | en_GB |
dc.title.alternative | Oxybenzopyridine | en_GB |
dc.title.alternative | Oxychinolin | en_GB |
dc.title.alternative | Oxyquinoline | en_GB |
dc.title.alternative | OXIN | en_GB |
dc.title.alternative | Phenopyridine | en_GB |
dc.title.alternative | Quinophenol | en_GB |
dc.title.alternative | Tumex | en_GB |
dc.title.alternative | Usaf ek-794 | en_GB |
dc.title.alternative | WLN: T66 BNJ JQ | en_GB |
dc.title.alternative | 1-Azanaphthalene-8-ol | en_GB |
dc.title.alternative | 8-Hydroxychinolin | en_GB |
dc.title.alternative | 8-Hydroxyquinoline | en_GB |
dc.title.alternative | 8-Oxyquinoline | en_GB |
dc.title.alternative | 8-OQ | en_GB |
dc.title.alternative | 8-Quinol | en_GB |
dc.title.alternative | 8-Quinolinol (8CI9CI) | en_GB |
dc.type | Chemical Structures | en_GB |